Historique
![Isotonitazene. Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_83440.webp?v=1771276960)
Rapport
Isotonitazene. Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
EVANS-BROWN, M. ;
GALLEGOS, A. ;
SEDEFOV, R. ;
ALMEIDA, A. ;
CHRISTIE, R. ;
DUQUE, P. ;
GALLEGOS, A. ;
JORGE, R. ;
DE MORAIS, J.
Année
2020
Page(s) :
55 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
Collection :
Risk assessments
Domaine :
Autres substances / Other substances
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
EUROPE
Thésaurus mots-clés
OPIOIDES
;
ANALGESIQUES
;
PHENOMENE EMERGENT
;
FACTEUR DE RISQUE
;
SURVEILLANCE EPIDEMIOLOGIQUE
;
CHIMIE
;
PHARMACOLOGIE
;
TOXICOLOGIE
Organismes
OEDT
Résumé :
This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on 26 May 2020. On the basis of the Risk Assessment Report, on 2 September 2020, the Commission decided that isotonitazene should be included in the definition of 'drug', in the Annex to Framework Decision 2004/757/JHA. Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with Commission Delegated Directive (EU) 2020/1687 by 3 June 2021.
Affiliation :
EMCDDA, Lisbon, Portugal ; iKem BT, Budapest, Hungary